Femasys Inc
NASDAQ:FEMY
Relative Value
The Relative Value of one FEMY stock under the Base Case scenario is 1.88 USD. Compared to the current market price of 1.27 USD, Femasys Inc is Undervalued by 33%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
FEMY Competitors Multiples
Femasys Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Femasys Inc
NASDAQ:FEMY
|
27.5m USD | 25.7 | -1.9 | -0.9 | -0.8 | ||
US |
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.6 | 33.1 | 19.5 | 29 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | ||
US |
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.2 | 40.3 | 25.1 | 31.1 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | ||
IE |
Medtronic PLC
NYSE:MDT
|
106B USD | 3.3 | 25.2 | 13.5 | 19.1 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 3.4 | 54.9 | 18.4 | 38.9 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 2.7 | 38.9 | 18.6 | 31.4 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.7 | 37 | 26.8 | 29 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 10.2 | 30.8 | 26.7 | 26.7 |